Health Research at a Crossroads
High-level experts from the European Commission and the pharmaceutical industry, as well as representatives of IMI projects and stakeholder groups, discussed the future of health research in Europe in front of a packed room at the European Parliament in Brussels on Tuesday 13 November.
The event, entitled Health Research at a Crossroads – Are Public-Private Partnerships the Way Forward? kicked off with presentations from the founding members of IMI, the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The presentations were followed by a debate on the need for and role of public-private partnerships in health research. There was broad agreement among the panellists that IMI enables unique collaboration between public and private partners in an open way that was not possible before. Panellists also discussed IMI's role in tackling knowledge fragmentation, and in creating a new culture of drug research and development.
The event was kindly hosted by Amalia Sartori MEP, Chair of the European Parliament’s Committee on Industry, Research and Energy.
- Download the final agenda
Download IMI's press release about the event.
- IMI – the story so far
Ruxandra Draghia-Akli, Director, DG Research & Innovation, European Commission
- IMI’s added value to the pharmaceutical industry
Roch Doliveux, Chief Executive Officer, UCB; Chair of the IMI Governing Board
Download the report of the event.